SCHEMBL30702146

SCHEMBL30702146

Nc1ccc2ncc(C(F)(F)F)nc2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC4 P56524 1/20 0.46
▸ TLR9 Q9NR96 2/20 0.42
▸ KDM4E B2RXH2 2/20 0.42
▸ MAPT P10636 2/20 0.42
▸ EGFR P00533 2/20 0.41
▸ CA2 P00918 1/20 0.40
▸ CHKA P35790 1/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ ATM Q13315 2/20 0.40
▸ HTT P42858 2/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ F2 P00734 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ CHRM2 P08172 1/20 0.39
▸ HTR1A P08908 1/20 0.39
▸ ADRA2A P08913 1/20 0.39
▸ ADORA3 P0DMS8 1/20 0.39
▸ MAOA P21397 1/20 0.39
▸ DRD1 P21728 1/20 0.39
▸ ACHE P22303 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20364203 1.00 HDAC4 (0.46) HDAC4TLR9KDM4EMAPTEGFR
Hydrochloric Acid SCHEMBL28218349 0.98 HDAC4 (0.45) HDAC4TLR9KDM4EMAPTEGFR
SCHEMBL20364204 0.93 TLR9 (0.50) HDAC4TLR9KDM4EMAPTEGFR
SCHEMBL30702108 0.93 TLR9 (0.50) HDAC4TLR9KDM4EMAPTEGFR
Hydrochloric Acid SCHEMBL28217861 0.91 TLR9 (0.49) HDAC4TLR9KDM4EMAPTEGFR
SCHEMBL1551266 0.82 TLR9 (0.42) TLR9KDM4EMAPTEGFRKMT2A
SCHEMBL20364207 0.79 NQO2 (0.46) HDAC4KDM4EMAPTHTTLMNA
SCHEMBL30134165 0.79 NT5E (0.54) HDAC4KDM4EMAPTHTTLMNA
SCHEMBL31184015 0.79 NQO2 (0.46) HDAC4KDM4EMAPTHTTLMNA
SCHEMBL20364201 0.79 NT5E (0.54) HDAC4KDM4EMAPTHTTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113292539-B Substituted oxopyridine derivatives 拜耳制药股份公司 2023-12-22 — — CN disclosed
Send feedback